(Q37462036)

20 August 2017

Risk estimation for the next generation of prevention programmes for cervical cancer (English)

1 reference

20 August 2017

cervix uterine cancer

1 reference

5

Mark Schiffman

1 reference

20 August 2017

2

Sholom Wacholder

1 reference

20 August 2017

4

Philip E Castle

1 reference

20 August 2017

1

Hormuzd A Katki

1 reference

20 August 2017

3

Diane Solomon

1 reference

20 August 2017

18 September 2009

1 reference

Lancet Oncology Commission

20 August 2017

1 reference

20 August 2017

10

1 reference

20 August 2017

1022-1023

1 reference

20 August 2017

11

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

HPV screening for cervical cancer in rural India

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

New technologies in cervical cancer screening

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

Risk assessment to guide the prevention of cervical cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2789459

Human papillomavirus and cervical cancer

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19767237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19767237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S1470-2045(09)70253-0

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

PMCID

2789459